相关实验视频

Updated: Jul 15, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

通过稳定SP1和促进SLC7A3介导的氨酸吸收,SIRPA增强骨髓瘤转移

Peng Wang¹, Yihui Song¹, Hongyu Li¹

¹Department of Orthopedics, The Eighth Affliated Hospital, Sun Yat-sen University, No. 3025 Shennan Zhong Road, Shenzhen, Guangdong, 518033, China.

|September 28, 2023

概括

信号调节蛋白α (SIRPA) 通过稳定特异性蛋白1 (SP1) 和增强氨酸吸收,促进骨髓瘤转移. 准SIRPA并阻止这种途径可能为骨髓瘤提供新的治疗方法.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

信号调节蛋白α (SIRPA) 功能已在免疫细胞中建立,但在瘤中不太了解.
在骨髓瘤 (OS) 中,SIRPA 升高调节,与预后不佳和转移相关.

研究的目的:

研究SIRPA在骨髓瘤转移中的作用.
阐明SIRPA介导的OS细胞迁移背后的分子机制,并确定潜在的治疗点.

主要方法:

在OS细胞中SIRPA的淘汰.
对特异性蛋白1 (SP1) 稳定性和酸化的分析.
通过溶解物载体家族7成员3 (SLC7A3) 评估阿金宁的吸收.
在体内异种移植研究中,结合了抗SIRPA抗体和阿基因酶治疗.

主要成果:

通过降低SP1稳定性和氨酸吸收,SIRPA knockdown减少了OS细胞迁移.
通过细胞外信号调节激酶 (ERK),SIRPA对SP1进行酸化,防止其降解.
SP1增强了SLC7A3的表达,增加了氨酸的吸收和OS细胞的迁移.
氨酸进一步稳定了SP1,形成了一个正反循环 ("SP1稳定圈").
联合抗SIRPA和阿基纳酶治疗在体内抑制了瘤转移.

结论:

升级的SIRPA驱动骨肉瘤转移通过"SP1稳定圈"和SLC7A3介导的阿尔金因吸收.
这一途径代表了骨髓瘤治疗的潜在治疗策略.

关键词:

阿尔吉尼因 (Arginine) 是一种素.转移转移转移转移骨质肉瘤骨质肉瘤是什么斯里帕斯 (SIRPA) 是一个.在SP1/SLC7A3A3中使用.

更多相关视频

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...